soman has been researched along with 6-cyano-7-nitroquinoxaline-2,3-dione in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Apland, JP; Aroniadou-Anderjaska, V; Braga, MF | 1 |
Albuquerque, EX; Alkondon, M; Pereira, EF | 1 |
2 other study(ies) available for soman and 6-cyano-7-nitroquinoxaline-2,3-dione
Article | Year |
---|---|
Soman induces ictogenesis in the amygdala and interictal activity in the hippocampus that are blocked by a GluR5 kainate receptor antagonist in vitro.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Alanine; Amygdala; Animals; Calcium; Evoked Potentials; Hippocampus; In Vitro Techniques; Male; Rats; Rats, Sprague-Dawley; Receptors, Kainic Acid; Seizures; Soman; Thymine | 2009 |
Acetylcholinesterase inhibition reveals endogenous nicotinic modulation of glutamate inputs to CA1 stratum radiatum interneurons in hippocampal slices.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Acetylcholine; Age Factors; Animals; Animals, Newborn; CA1 Region, Hippocampal; Cholinesterase Inhibitors; Donepezil; Electric Stimulation; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Glutamic Acid; Guinea Pigs; In Vitro Techniques; Indans; Interneurons; Lethal Dose 50; Male; Mecamylamine; Nicotine; Nicotinic Antagonists; Patch-Clamp Techniques; Piperidines; Rats; Soman | 2013 |